Solventum Corp
Solventum
SOLV · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $8.3B
- Assets
- $14.3B
- SEC filing
- DEF 14A
- Filed
- March 27, 2026
Executive Compensation
Compensation reported for Solventum’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Bryan C. Hanson
Chief Executive Officer
$20.1M
Reported total
- Salary
- $1,350,000
- Stock awards
- $15,209,022
- Incentives
- $2,988,900
- Option awards
- $0
- Other
- $592,058
Heather Knight
Chief Commercial Officer
$7.9M
Reported total
- Salary
- $112,821
- Stock awards
- $5,653,534
- Incentives
- $2,140,186
- Option awards
- $0
- Other
- $11,365
Wayde D. McMillan
Chief Financial Officer
$6.2M
Reported total
- Salary
- $773,229
- Stock awards
- $4,195,688
- Incentives
- $1,118,221
- Option awards
- $0
- Other
- $78,445
Christopher Barry
Former Evp And Group President, Medical Surgical
$4.2M
Reported total
- Salary
- $996,750
- Stock awards
- $3,146,700
- Incentives
- $0
- Option awards
- $0
- Other
- $88,553
Marcela A. Kirberger
Chief Corporate & Legal Officer
$3.6M
Reported total
- Salary
- $728,651
- Stock awards
- $1,992,885
- Incentives
- $773,085
- Option awards
- $0
- Other
- $99,396
Amy L. Landucci
Chief Information &digital Officer
$3.5M
Reported total
- Salary
- $684,875
- Stock awards
- $1,809,409
- Incentives
- $871,969
- Option awards
- $0
- Other
- $98,723
Bryan C. Hanson
Chief Executive Officer
$20.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 27, 2026.
- Salary
- $1.4M
- Stock Awards
- $15.2M
- Incentives
- $3M
- Other
- $592K
Historical Compensation
Bryan C. Hanson total compensation, fiscal years 2024–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,350,000 | $15,209,022 | $20,139,981 |
| 2024 | $1,350,000 | $29,589,286 | $39,959,767 |
Named Executive Officers
Bryan C. Hanson
Chief Executive Officer
Solventum · SOLV
$20.1M
FY 2025 · DEF 14A
Wayde D. McMillan
Chief Financial Officer
Solventum · SOLV
$6.2M
FY 2025 · DEF 14A
Heather Knight
Chief Commercial Officer
Solventum · SOLV
$7.9M
FY 2025 · DEF 14A
Marcela A. Kirberger
Chief Corporate & Legal Officer
Solventum · SOLV
$3.6M
FY 2025 · DEF 14A
Amy L. Landucci
Chief Information &digital Officer
Solventum · SOLV
$3.5M
FY 2025 · DEF 14A
Christopher Barry
Former Evp And Group President, Medical Surgical
Solventum · SOLV
$4.2M
FY 2025 · DEF 14A
Source information
- Company
- Solventum Corp
- Ticker
- SOLV · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 27, 2026
- SEC accession number
- 0001964738-26-000017
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company